Essex Woodlands Healthcare Partners

The record

Every round we can evidence, newest first62 appearances

1. 2014

   1 round

2. Jan
   Qspex TechnologiesDebt · US$15MWith 1 other
3. 2013

   3 rounds

4. Sept
   PreCision DermatologyDebt · US · pehub.com$67MWith 7 others
5. Apr
   Revance TherapeuticsSeries E · US · biocentury.com$33MWith 2 others
6. Apr
   Catalyst BiosciencesVenture · US$5.1MWith 5 others
7. 2012

   8 rounds

8. Dec
   Kona MedicalSeries C · US · bizjournals.com$10MWith 4 others
9. Nov
   BreatheAmericaGrowth · US · sec.gov$5.0MSole investor
10. Oct
    IntegenXVenture · US$9.4MWith 3 others
11. Sept
    Catalyst BiosciencesVenture · US · sec.gov$13MWith 4 others
12. Jul
    IntegenXGrowth · US$14MWith 1 other
13. Jun
    Qspex TechnologiesSeries D · US · qspex.com$21MWith 1 other
14. May
    Kona MedicalSeries C · US · finsmes.com$30MWith 3 others
15. May
    NeoVistaVenture · US$6.0MWith 4 others
16. 2011

    6 rounds

17. Dec
    IntegenXSeries C · US$40MWith 6 others
18. Sept
    BreatheAmericaSeries B · US · finsmes.com$22MSole investor
19. Aug
    Entellus MedicalSeries E · US · finsmes.com$35MWith 4 others
20. Jun
    Revance TherapeuticsSeries D · US · finsmes.com$45MWith 6 others
21. Feb
    NeoVistaSeries E · US · fis.dowjones.com$33MWith 5 others
22. Jan
    SymphogenGrowth · DK · finsmes.com$131MWith 2 others
23. 2010

    8 rounds

24. Nov
    Revance TherapeuticsSeries D · US · sec.gov$36MWith 4 others
25. Oct
    EndologixVenture · US · investor.endologix.com$15MSole investor
26. Oct
    CellBiosciencesSeries F · US · xconomy.com$20MWith 7 others
27. Sept
    AccumetricsVenture · US · finsmes.com$7.0MWith 5 others
28. Aug
    Complete GenomicsSeries E · US · completegenomics.com$39MWith 6 others
29. May
    TearScienceSeries C · US · onbiovc.com$45MWith 5 others
30. Jan
    AccumetricsSeries E · US · onbiovc.com$17MWith 5 others
31. Jan
    ikaSystemsGrowth · US · fis.dowjones.com$120MSole investor
32. 2009

    8 rounds

33. Dec
    Molecular PartnersSeries B · CH · fis.dowjones.com$44MWith 5 others
34. Nov
    Entellus MedicalSeries D · US · news.morningstar.com$30MWith 2 others
35. Oct
    XanodyneSeries D · US$88MWith 6 others
36. Aug
    Complete GenomicsSeries D · US · fiercebiotech.com$45MWith 5 others
37. Jul
    Oraya TherapeuticsSeries C · US · fiercebiotech.com$42MWith 3 others
38. Jun
    XanodyneSeries D · US · onbiovc.com$38MWith 6 others
39. Jun
    Chroma TherapeuticsVenture · GB$25MWith 5 others
40. Feb
    SymphogenGrowth · DK · symphogen.com$42MSole investor
41. 2008

    4 rounds

42. Dec
    Catalyst BiosciencesSeries C · US · fiercebiotech.com$40MWith 6 others
43. Mar
    NellixSeries C · US · deals.venturebeat.com$6.5MWith 1 other
44. Feb
    AccumetricsSeries D · US · prnewswire.com$29MWith 7 others
45. Jan
    Oraya TherapeuticsSeries B · US · venturebeat.com$18MWith 1 other
46. 2007

    9 rounds

47. Dec
    Revance TherapeuticsSeries C · US$43MWith 5 others
48. Sept
    Corium InternationalSeries C · US · coriumgroup.com$40MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed11 in all

An exit counts when it came after the firm's first round in the company. From historical deal records.